Preclinical data further support the potential of dual-antigen and TGF-β-directed vaccines to reshape the tumor microenvironment and drive anti-tumor immunity NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) ...

The burden of babesiosis disease was significantly worse among patients with vs without immunocompromising conditions.

Piper Sandler analyst Allison Bratzel maintained a Buy rating on Scholar Rock Holding (SRRK – Research Report) today. The company’s shares ...

In our weekly column, Quick Bites, we round up the latest developments in the alt-protein and sustainable food industry.

Dow Jones Industrial Average futures rose 506 points, or 1.3%. Futures tied to the S&P 500 popped 1.6%, while Nasdaq 100 ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Atreo, the next generation Randomization and Trial Supply Management (RTSM) provider, has released its groundbreaking v2.0 Platform. Specifically designed in collaboration with large pharmaceutical ...

Shares of Iovance Biotherapeutics have plummeted post-Amtagvi approval. Read more to see a full investment analysis for IOVA ...

Michael Saylor hints at expanding Bitcoin holdings as 13K+ institutions gain exposure to MicroStrategy, strengthening its ...

Expressing “loss of faith” in the investigation carried out by the Gujarat police so far, the petitioner said the probe ...